182 related articles for article (PubMed ID: 33769289)
1. Do the combination of multiparametric MRI-based radiomics and selected blood inflammatory markers predict the grade and proliferation in glioma patients?
Guo J; Ren J; Shen J; Cheng R; He Y
Diagn Interv Radiol; 2021 May; 27(3):440-449. PubMed ID: 33769289
[TBL] [Abstract][Full Text] [Related]
2. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
Lin K; Cidan W; Qi Y; Wang X
Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract][Full Text] [Related]
5. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
6. Elaboration of Multiparametric MRI-Based Radiomics Signature for the Preoperative Quantitative Identification of the Histological Grade in Patients With Non-Small-Cell Lung Cancer.
Tang X; Bai G; Wang H; Guo F; Yin H
J Magn Reson Imaging; 2022 Aug; 56(2):579-589. PubMed ID: 35040525
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI radiomics for the differentiation of brain glial cell hyperplasia from low-grade glioma.
Gu S; Qian J; Yang L; Sun Z; Hu C; Wang X; Hu S; Xie Y
BMC Med Imaging; 2023 Aug; 23(1):116. PubMed ID: 37653513
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
[TBL] [Abstract][Full Text] [Related]
9. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
[TBL] [Abstract][Full Text] [Related]
10. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
[TBL] [Abstract][Full Text] [Related]
11. The value of multiparametric MRI radiomics in predicting IDH genotype in glioma before surgery.
Liang Y; Liu W; Bai D; Hu J; Wang Z
Front Oncol; 2023; 13():1265672. PubMed ID: 38090497
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing brain inflammation from grade II glioma in population without contrast enhancement: a radiomics analysis based on conventional MRI.
Han Y; Yang Y; Shi ZS; Zhang AD; Yan LF; Hu YC; Feng LL; Ma J; Wang W; Cui GB
Eur J Radiol; 2021 Jan; 134():109467. PubMed ID: 33307462
[TBL] [Abstract][Full Text] [Related]
13. Exploring the association of glioma tumor residuals from incongruent [
Li X; Cheng Y; Han X; Cui B; Li J; Yang H; Xu G; Lin Q; Xiao X; Tang J; Lu J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):779-796. PubMed ID: 37864593
[TBL] [Abstract][Full Text] [Related]
14. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
15. MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.
Wu C; Zheng H; Li J; Zhang Y; Duan S; Li Y; Wang D
Eur Radiol; 2022 Mar; 32(3):1813-1822. PubMed ID: 34655310
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral and Peritumoral Multiparametric MRI-Based Radiomics Signature for Preoperative Prediction of Ki-67 Proliferation Status in Glioblastoma: A Two-Center Study.
Zhu X; He Y; Wang M; Shu Y; Lai X; Gan C; Liu L
Acad Radiol; 2024 Apr; 31(4):1560-1571. PubMed ID: 37865602
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
19. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
[TBL] [Abstract][Full Text] [Related]
20. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
